Cell Leukodystrophy (Krabbe Disease) Market Report

China Cell Leukodystrophy (Krabbe Disease) Industry Market Research Report 2023-2029

  • POSTDATE：Aug 26, 2023
  • PAGES：202
  • REPORT CODE：GMM1756891
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessive pattern. The disease is named after the Danish neurologist Knud Krabbe (1885–1965).

    This report elaborates on the current development of the Cell Leukodystrophy (Krabbe Disease) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis AG

    • Abbott Laboratories

    • ​​Johnson＆Johnson

    • UCB Pharmaceuticals

    • Sanofi SA

    • Shire

    • Pfizer

    • Teva Pharmaceutical Industries Ltd

    By Type:

    • 15 months - 10 years old

    • 3-6 months

    By Application:

    • Research centers

    • Clinics

    • Others

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Cell Leukodystrophy (Krabbe Disease) Market Overview 2018-2029

    • 1.1 China Cell Leukodystrophy (Krabbe Disease) Industry Development Overview

    • 1.2 China Cell Leukodystrophy (Krabbe Disease) Industry Development History

    • 1.3 China Cell Leukodystrophy (Krabbe Disease) Industry Market Size (2018-2029)

    • 1.4 China Cell Leukodystrophy (Krabbe Disease) Market Analysis by Type from Production Side

      • 1.4.1 China Cell Leukodystrophy (Krabbe Disease) Production Volume, Production Value and Growth Rate of 15 months - 10 years old (2018-2029)

      • 1.4.2 China Cell Leukodystrophy (Krabbe Disease) Production Volume, Production Value and Growth Rate of 3-6 months (2018-2029)

    • 1.5 China Cell Leukodystrophy (Krabbe Disease) Market Analysis by Application from Consumption End

      • 1.5.1 China Cell Leukodystrophy (Krabbe Disease) Sales Volume, Sales Value and Growth Rate of Research centers (2018-2029)

      • 1.5.2 China Cell Leukodystrophy (Krabbe Disease) Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.3 China Cell Leukodystrophy (Krabbe Disease) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Cell Leukodystrophy (Krabbe Disease) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Cell Leukodystrophy (Krabbe Disease) Market Analysis by Region

      • 1.6.1 North China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Cell Leukodystrophy (Krabbe Disease) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Cell Leukodystrophy (Krabbe Disease) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Cell Leukodystrophy (Krabbe Disease) Market Status and Competition Analysis in 2023

      • 2.2.3 China Cell Leukodystrophy (Krabbe Disease) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Cell Leukodystrophy (Krabbe Disease) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Cell Leukodystrophy (Krabbe Disease) Industry Development

    Chapter 3 Cell Leukodystrophy (Krabbe Disease)Industry Chain Analysis

    • 3.1 Cell Leukodystrophy (Krabbe Disease) Industry Chain

    • 3.2 Cell Leukodystrophy (Krabbe Disease) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Cell Leukodystrophy (Krabbe Disease) Market

    • 3.3 Cell Leukodystrophy (Krabbe Disease) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Cell Leukodystrophy (Krabbe Disease) Market

    Chapter 4 China Cell Leukodystrophy (Krabbe Disease) Market, by Type

    • 4.1 China Cell Leukodystrophy (Krabbe Disease) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Cell Leukodystrophy (Krabbe Disease) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Cell Leukodystrophy (Krabbe Disease) Production Volume and Growth Rate, by Type

      • 4.5.1 China Cell Leukodystrophy (Krabbe Disease) Production Volume and Growth Rate of 15 months - 10 years old

      • 4.5.2 China Cell Leukodystrophy (Krabbe Disease) Production Volume and Growth Rate of 3-6 months

    Chapter 5 China Cell Leukodystrophy (Krabbe Disease) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Cell Leukodystrophy (Krabbe Disease) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate, by Application

      • 5.5.1 China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate of Research centers

      • 5.5.2 China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate of Clinics

      • 5.5.3 China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate of Others

      • 5.5.4 China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate of Hospitals

    Chapter 6 China Cell Leukodystrophy (Krabbe Disease) Market, by Region

    • 6.1 China Cell Leukodystrophy (Krabbe Disease) Production Volume and Production Value, by Region

    • 6.2 China Cell Leukodystrophy (Krabbe Disease) Sales Volume and Sales Value, by Region

    Chapter 7 North China Cell Leukodystrophy (Krabbe Disease) Market Analysis

    • 7.1 North China Cell Leukodystrophy (Krabbe Disease) Market, by Type

    • 7.2 North China Cell Leukodystrophy (Krabbe Disease) Market, by Application

    Chapter 8 Central China Cell Leukodystrophy (Krabbe Disease) Market Analysis

    • 8.1 Central China Cell Leukodystrophy (Krabbe Disease) Market, by Type

    • 8.2 Central China Cell Leukodystrophy (Krabbe Disease) Market, by Application

    Chapter 9 South China Cell Leukodystrophy (Krabbe Disease) Market Analysis

    • 9.1 South China Cell Leukodystrophy (Krabbe Disease) Market, by Type

    • 9.2 South China Cell Leukodystrophy (Krabbe Disease) Market, by Application

    Chapter 10 East China Cell Leukodystrophy (Krabbe Disease) Market Analysis

    • 10.1 East China Cell Leukodystrophy (Krabbe Disease) Market, by Type

    • 10.2 East China Cell Leukodystrophy (Krabbe Disease) Market, by Application

    Chapter 11 Northeast China Cell Leukodystrophy (Krabbe Disease) Market Analysis

    • 11.1 Northeast China Cell Leukodystrophy (Krabbe Disease) Market, by Type

    • 11.2 Northeast China Cell Leukodystrophy (Krabbe Disease) Market, by Application

    Chapter 12 Southwest China Cell Leukodystrophy (Krabbe Disease) Market Analysis

    • 12.1 Southwest China Cell Leukodystrophy (Krabbe Disease) Market, by Type

    • 12.2 Southwest China Cell Leukodystrophy (Krabbe Disease) Market, by Application

    Chapter 13 Northwest China Cell Leukodystrophy (Krabbe Disease) Market Analysis

    • 13.1 Northwest China Cell Leukodystrophy (Krabbe Disease) Market, by Type

    • 13.2 Northwest China Cell Leukodystrophy (Krabbe Disease) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis AG

        • 14.1.1 Novartis AG Company Profile

        • 14.1.2 Novartis AG Cell Leukodystrophy (Krabbe Disease) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Abbott Laboratories

        • 14.2.1 Abbott Laboratories Company Profile

        • 14.2.2 Abbott Laboratories Cell Leukodystrophy (Krabbe Disease) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 ​​Johnson＆Johnson

        • 14.3.1 ​​Johnson＆Johnson Company Profile

        • 14.3.2 ​​Johnson＆Johnson Cell Leukodystrophy (Krabbe Disease) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 UCB Pharmaceuticals

        • 14.4.1 UCB Pharmaceuticals Company Profile

        • 14.4.2 UCB Pharmaceuticals Cell Leukodystrophy (Krabbe Disease) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Sanofi SA

        • 14.5.1 Sanofi SA Company Profile

        • 14.5.2 Sanofi SA Cell Leukodystrophy (Krabbe Disease) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Shire

        • 14.6.1 Shire Company Profile

        • 14.6.2 Shire Cell Leukodystrophy (Krabbe Disease) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Pfizer

        • 14.7.1 Pfizer Company Profile

        • 14.7.2 Pfizer Cell Leukodystrophy (Krabbe Disease) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Teva Pharmaceutical Industries Ltd

        • 14.8.1 Teva Pharmaceutical Industries Ltd Company Profile

        • 14.8.2 Teva Pharmaceutical Industries Ltd Cell Leukodystrophy (Krabbe Disease) Market Performance

        • 14.8.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Cell Leukodystrophy (Krabbe Disease) Industry Research Conclusions

    • 15.2 Cell Leukodystrophy (Krabbe Disease) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Cell Leukodystrophy (Krabbe Disease) Industry Market Size (2018-2029)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Production Volume, Production Value and Growth Rate of 15 months - 10 years old (2018-2029)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Production Volume, Production Value and Growth Rate of 3-6 months (2018-2029)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Sales Volume, Sales Value and Growth Rate of Research centers (2018-2029)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

    • Figure Central China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

    • Figure South China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

    • Figure East China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate from 2018-2029

    • Figure Cell Leukodystrophy (Krabbe Disease) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Cell Leukodystrophy (Krabbe Disease) Market Share by Type in 2018

    • Figure China Cell Leukodystrophy (Krabbe Disease) Market Share by Type in 2023

    • Figure China Cell Leukodystrophy (Krabbe Disease) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Production Volume and Growth Rate of 15 months - 10 years old (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Production Volume and Growth Rate of 3-6 months (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Market Share by Application in 2018

    • Figure China Cell Leukodystrophy (Krabbe Disease) Market Share by Application in 2023

    • Figure China Cell Leukodystrophy (Krabbe Disease) Total Market Size and Growth Rate from Consumption End

    • Figure China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate of Research centers (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate of Others (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Cell Leukodystrophy (Krabbe Disease) Production Volume by Region (2018-2023)

    • Table China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Region (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Region (2018-2023)

    • Table China Cell Leukodystrophy (Krabbe Disease) Production Value by Region (2018-2023)

    • Table China Cell Leukodystrophy (Krabbe Disease) Production Value Share by Region (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Production Value Share by Region (2018-2023)

    • Table China Cell Leukodystrophy (Krabbe Disease) Sales Volume by Region (2018-2023)

    • Table China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Region (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Region (2018-2023)

    • Table China Cell Leukodystrophy (Krabbe Disease) Sales Value by Region (2018-2023)

    • Table China Cell Leukodystrophy (Krabbe Disease) Sales Value Share by Region (2018-2023)

    • Figure China Cell Leukodystrophy (Krabbe Disease) Sales Value Share by Region (2018-2023)

    • Table North China Cell Leukodystrophy (Krabbe Disease) Production Volume by Type (2018-2023)

    • Table North China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Figure North China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Table North China Cell Leukodystrophy (Krabbe Disease) Sales Volume by Application (2018-2023)

    • Table North China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Figure North China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Table Central China Cell Leukodystrophy (Krabbe Disease) Production Volume by Type (2018-2023)

    • Table Central China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Figure Central China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Table Central China Cell Leukodystrophy (Krabbe Disease) Sales Volume by Application (2018-2023)

    • Table Central China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Figure Central China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Table South China Cell Leukodystrophy (Krabbe Disease) Production Volume by Type (2018-2023)

    • Table South China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Figure South China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Table South China Cell Leukodystrophy (Krabbe Disease) Sales Volume by Application (2018-2023)

    • Table South China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Figure South China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Table East China Cell Leukodystrophy (Krabbe Disease) Production Volume by Type (2018-2023)

    • Table East China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Figure East China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Table East China Cell Leukodystrophy (Krabbe Disease) Sales Volume by Application (2018-2023)

    • Table East China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Figure East China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Cell Leukodystrophy (Krabbe Disease) Production Volume by Type (2018-2023)

    • Table Northeast China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Table Northeast China Cell Leukodystrophy (Krabbe Disease) Sales Volume by Application (2018-2023)

    • Table Northeast China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Cell Leukodystrophy (Krabbe Disease) Production Volume by Type (2018-2023)

    • Table Southwest China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Table Southwest China Cell Leukodystrophy (Krabbe Disease) Sales Volume by Application (2018-2023)

    • Table Southwest China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Cell Leukodystrophy (Krabbe Disease) Production Volume by Type (2018-2023)

    • Table Northwest China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Cell Leukodystrophy (Krabbe Disease) Production Volume Share by Type (2018-2023)

    • Table Northwest China Cell Leukodystrophy (Krabbe Disease) Sales Volume by Application (2018-2023)

    • Table Northwest China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Cell Leukodystrophy (Krabbe Disease) Sales Volume Share by Application (2018-2023)

    • Table Novartis AG Company Profile

    • Table Novartis AG Cell Leukodystrophy (Krabbe Disease) Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories Company Profile

    • Table Abbott Laboratories Cell Leukodystrophy (Krabbe Disease) Revenue, Price and Gross (2018-2023)

    • Table ​​Johnson＆Johnson Company Profile

    • Table ​​Johnson＆Johnson Cell Leukodystrophy (Krabbe Disease) Revenue, Price and Gross (2018-2023)

    • Table UCB Pharmaceuticals Company Profile

    • Table UCB Pharmaceuticals Cell Leukodystrophy (Krabbe Disease) Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Cell Leukodystrophy (Krabbe Disease) Revenue, Price and Gross (2018-2023)

    • Table Shire Company Profile

    • Table Shire Cell Leukodystrophy (Krabbe Disease) Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Cell Leukodystrophy (Krabbe Disease) Revenue, Price and Gross (2018-2023)

    • Table Teva Pharmaceutical Industries Ltd Company Profile

    • Table Teva Pharmaceutical Industries Ltd Cell Leukodystrophy (Krabbe Disease) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US